The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
20 categories

Clinical

Laboratory interpretation, comorbidities, special populations, and preparing for a conversation with your own prescriber. General information only.

96 topics4,480 posts30 solved Moderators: bench_notes, hana.sato About this category

96 topics · page 3 of 4

TopicParticipantsRepliesViewsActivity
Asking about a compound your prescriber has not heard of
Asking about a compound your prescriber has not heard of Writing it up because I had to work it out twice and would rather nobody else did. A question about how to describe something to a clinician rather…
SLLKKKKC+137 148 15k 11mo
[2026 update] Cardiovascular risk: reading the outcome trials as a set
Posting this under the heading it deserves: Cardiovascular risk: reading the outcome trials as a set Everything below is what sits behind that. I have spent a fortnight trying to pin Cardiovascular risk down…
SOAWKRLDNL+99 103 32k 11mo
Preparing for an appointment: one page, three questions
Posting this under the heading it deserves: Preparing for an appointment: one page, three questions Everything below is what sits behind that. A question about how to describe something to a clinician rather…
LGDAMIDA+28 32 57k 11mo
Older adults, sarcopenia risk, and the trade-off nobody quantifies — does this still hold?
Asking directly, because I could not find a straight answer: Older adults, sarcopenia risk, and the trade-off nobody quantifies — does this still hold? Older adults: setting out the arithmetic in full,…
EFBPWM 2 22k 11mo
Biological variation versus analytical imprecision
On the subject in the title: Biological variation versus analytical imprecision Working notes rather than a conclusion. A question about biological variation versus analytical imprecision that I think has a…
FFSSJA 2 42k 12mo
Discussing something you have already been doing — the long version
Discussing something you have already been doing — the long version Writing it up because I had to work it out twice and would rather nobody else did. A question about how to describe something to a clinician…
ITATALENG+14 18 58k 12mo
Hepatic steatosis: what the MASH trial evidence supports
Hepatic steatosis: what the MASH trial evidence supports — setting out what I have, and where I think it stops being reliable. Trying to work out what would count as evidence on hepatic steatosis, before…
CMPCNLSMA+77 83 950 13mo
Obstructive sleep apnoea and a hard endpoint in this class
On the subject in the title: Obstructive sleep apnoea and a hard endpoint in this class Working notes rather than a conclusion. I was wrong about obstructive sleep apnoea in a thread last spring and I would…
OBFATWAKMS+120 129 1.8k 13mo
[2026 update] Gastro-oesophageal reflux: improving or worsening?
Asking directly, because I could not find a straight answer: Gastro-oesophageal reflux: improving or worsening? Gastro-oesophageal reflux — I have the observation and I do not trust my interpretation of it,…
EFFIMDN 3 782 13mo
Lipase elevation without symptoms: the interpretation problem — a second dataset
Posting this under the heading it deserves: Lipase elevation without symptoms: the interpretation problem — a second dataset Everything below is what sits behind that. Posting a small dataset on Lipase…
TBJBPJSMS+6 15 2.2k 13mo
Coming back to: Getting a referral rather than a refusal
Posting this under the heading it deserves: Getting a referral rather than a refusal Everything below is what sits behind that. Working notes on Getting a referral rather than a conclusion. I would rather…
BNTVNLVMM+69 74 1.7k 13mo
How to bring a laboratory report to an appointment usefully
How to bring a laboratory report to an appointment usefully — that is the question, and I have not found it answered plainly anywhere I have looked. Asking about bring a laboratory directly, because I have…
TVCHG 2 41k 14mo
[2026 update] Building a sensible monitoring schedule with your prescriber
Posting this under the heading it deserves: Building a sensible monitoring schedule with your prescriber Everything below is what sits behind that. Reading back through what has been written here about…
NKAWTSKAAD+22 26 5.1k 14mo
HbA1c lag and what it can and cannot tell you at eight weeks
HbA1c lag and what it can and cannot tell you at eight weeks Writing it up because I had to work it out twice and would rather nobody else did. Something about hba1c lag does not reconcile and I would like a…
JMMPKRVNK+14 18 2.6k 14mo
Second pass at: Obstructive sleep apnoea and a hard endpoint in this class
Second pass at: Obstructive sleep apnoea and a hard endpoint in this class — setting out what I have, and where I think it stops being reliable. Something about Obstructive sleep apnoea does not reconcile and…
SVCLRF 2 726 14mo
Micronutrient status when intake falls substantially — a second dataset
Micronutrient status when intake falls substantially — a second dataset Writing it up because I had to work it out twice and would rather nobody else did. Posting a small dataset on Micronutrient status. It…
MMNMYLMSL+9 13 274 14mo
Second pass at: A single out-of-range value on an otherwise normal panel
Second pass at: A single out-of-range value on an otherwise normal panel Writing it up because I had to work it out twice and would rather nobody else did. General question, not a request for advice about my…
OVTVINCRSO+9 13 8.5k 16mo
Revisiting: Heart failure with preserved ejection fraction: symptom endpoints
On the subject in the title: Revisiting: Heart failure with preserved ejection fraction: symptom endpoints Working notes rather than a conclusion. Working notes on Heart failure with preserved ejection rather…
SPDBOCASCN+4 8 43k 17mo
[2026 update] Lipid changes during rapid weight loss: the expected trajectory
Lipid changes during rapid weight loss: the expected trajectory Writing it up because I had to work it out twice and would rather nobody else did. Lipid changes during rapid weight keeps being re-asked here…
FHMMHBRVSK+51 56 7.1k 17mo
Coming back to: Renal impairment: what the labelling says about dose
Renal impairment: what the labelling says about dose — setting out what I have, and where I think it stops being reliable. Renal impairment — I have the observation and I do not trust my interpretation of it,…
NGDBCTJROF+30 34 48k 18mo
Gallbladder disease risk with rapid weight loss
Posting this under the heading it deserves: Gallbladder disease risk with rapid weight loss Everything below is what sits behind that. Gallbladder disease risk — I have the observation and I do not trust my…
IBRIJVPYR+56 63 34k 18mo
Coming back to: Preparing for an appointment: one page, three questions
Posting this under the heading it deserves: Preparing for an appointment: one page, three questions Everything below is what sits behind that. A question about how to describe something to a clinician rather…
MSTMLSCNAS+139 151 47k 18mo
Renal impairment: what the labelling says about dose
On the subject in the title: Renal impairment: what the labelling says about dose Working notes rather than a conclusion. A methods question rather than a substantive one, about renal impairment. Everyone…
OVJPZOFKJB 4 8.9k 19mo
People with a low starting BMI: where the evidence stops
Posting this under the heading it deserves: People with a low starting BMI: where the evidence stops Everything below is what sits behind that. Asking about a population rather than about a person. The…
VFJDSOAWAW+23 27 5.8k 19mo
Building a sensible monitoring schedule with your prescriber
Building a sensible monitoring schedule with your prescriber — setting out what I have, and where I think it stops being reliable. Building a sensible monitoring schedule — I have the observation and I do not…
SGRIGEFAC+91 108 52k 19mo
Second opinions: how to seek one without burning the first
Second opinions: how to seek one without burning the first Writing it up because I had to work it out twice and would rather nobody else did. The question about second opinions that I actually want answered…
QZBOSRDNEM+1 5 33k 19mo
Asking about a compound your prescriber has not heard of — one year on
On the subject in the title: Asking about a compound your prescriber has not heard of — one year on Working notes rather than a conclusion. A question about how to describe something to a clinician rather…
ESMHKDOBSG+11 15 3.7k 19mo
Type 1 diabetes: off-label use and the evidence gap — what changed since
Type 1 diabetes: off-label use and the evidence gap — what changed since — setting out what I have, and where I think it stops being reliable. What changes if the standard account of Type 1 diabetes is wrong?…
SOKRZSNTSD+68 77 31k 20mo
How to ask for a dose change without antagonising anyone — what changed since
How to ask for a dose change without antagonising anyone — what changed since — that is the question, and I have not found it answered plainly anywhere I have looked. A question about how to describe…
RVHKTDESAA+81 92 10k 20mo
Chronic kidney disease and the FLOW result — a second dataset
Chronic kidney disease and the FLOW result — a second dataset Writing it up because I had to work it out twice and would rather nobody else did. Posting a small dataset on Chronic kidney disease. It is mine,…
CTMMHH 2 2.3k 20mo